SEC Comment Letter 0000000000-23-012576 to Longeveron Inc. (LGVN)
Longeveron Inc.
Date: Nov. 16, 2023 · CIK: 0001721484 · Accession: 0000000000-23-012576
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275578
Letter
United States securities and exchange commission logo November 16, 2023 Wa’el Hashad Chief Executive Officer Longeveron Inc. 1951 NW 7th Avenue, Suite 520 Miami, Florida 33136 Re:Longeveron Inc. Registration Statement on Form S-1 Filed November 15, 2023 File No. 333-275578 Dear Wa’el Hashad: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer Minter, Esq.
Show Raw Text
United States securities and exchange commission logo
November 16, 2023
Wa’el Hashad
Chief Executive Officer
Longeveron Inc.
1951 NW 7th Avenue, Suite 520
Miami, Florida 33136
Re:Longeveron Inc.
Registration Statement on Form S-1
Filed November 15, 2023
File No. 333-275578
Dear Wa’el Hashad:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jennifer Minter, Esq.